References
Amitai M, Dickhaut HH, Hasenknopf P (1972) Behandlung des Entzugs-Syndroms bei “Fixern” (Rauschmittelmißbrauch Jugendlicher p.Inj.) Nervenarzt 42:157–160
Amsler C (1923) Beiträge zur Pharmakologie des Gehirns. Arch Exp Pathol Pharmakol 2:1–14
Andén N-E, Rubensson A, Fuxe, K, Hökfelt T (1967) Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol 19:627–629
Birkmayer W, Hornykiewicz O (1961) Der L-3,4-Dioxyphenylalanin (= DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73:787–788
Blaschko H (1957) Metabolism and storage of biogenic amines. Experientia 13:9–12
Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140–144
DiChiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278
Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 38:1236–1239
Ernst AM (1967) Mode of action of apomorphine and dexamphetamine in gnawing compulsion in rats. Psychopharmacol 10:316–323
Giessler C, Giessler J (2004) Institut für Pharmakologie und Toxikologie, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg. In: Philippu A (ed) Geschichte und Wirken der pharmakologischen, klinisch-pharmakologischen und toxikologischen Institute im deutschsprachigen Raum. Berenkamp, Innsbruck, pp 287–297
Hornykiewicz O (2001) How L-DOPA was discovered as a drug for Parkinson´s desease 40 years ago. Wiener Klin Wochenschrift 113:855–862
Kuschinsky K (1976) Actions of narcotics on brain dopamine metabolism and their relevance for “psychomotor” effects. Arzneimittel-Forschung (Drug Research) 26:563–567
Luippold G, Beilharz M, Wehrmann M, Unger L, Gross, G, Mühlbauer G (2005) Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats. Naunyn-Schmiedeberg’s Arch Pharmacol 371:420–427
Pavone C, Curto F, Anello G, Serretta V, Almasio PL, Pavone-Macaluso M (2004) Prospective, randomized crossover comparison of sublingual apomorphine (3 mg) and oral sildenafil (50 mg) for male erectile dysfunction. J Urol 172:2347–2349
Yokel RA (1987) Intravenous self-administration: Response rates, the effects of pharmacological challenges, and drug preference. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, Berlin Heidelberg New York, pp 1–33
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuschinsky, K. An anthology from Naunyn-Schmiedeberg’s archives of pharmacology. Naunyn-Schmied Arch Pharmacol 373, 387–389 (2006). https://doi.org/10.1007/s00210-006-0089-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-006-0089-7